摘要
目的:观察健脾柔肝汤治疗慢性肝炎肝纤维化的临床疗效。方法:将60例患者随机均分为治疗组和对照组,两组治疗均采用西药保肝对症疗法,治疗组加用健脾柔肝汤治疗。观察治疗前后肝纤维化血清4项(PCⅢ、HA、LN、Ⅳ-C)及免疫功能变化及不良反应。结果:中医证候疗效比较,治疗组与对照组有效率分别为83.3%、60.0%(P<0.05)。治疗组对肝纤维化血清4项的治疗后复常率显著优于对照组(P<0.01)。治疗组治疗后T淋巴细胞亚群比值升高,CD+8降低(P<0.05),对照组治疗前后上述指标比较,差异无显著性(P>0.05)。结论:健脾柔肝汤能减轻肝组织内部肝纤维化增生,并有促肝细胞再生作用,提高机体免疫功能,从而达到抗纤维化作用。
Objective : To observe the clinical curative effect of jianpirougan decoction in the treatment of chronic hepatitis B liver fibrosis. Methods: 60 cases were randomly divided into the treatment group and control group on average, two groups were treated by western medicine with protecting liver, treatment group were added jianpirougan tang . Observe liver fibrosis PC III serum 4, HA, LN, IV - C before and after the treatment and the immune function changes and adverse reaction. Results : The curative effect of TCM syndrome, the effective rate of treatment group and control group was respectively 83.3% , 60.0% ( P 〈 0.05 ). Treatment group of liver fibrosis was significantly better than control group often rate (P 〈 0.01 ). After the treatment group therapy T lymphocyte subsets ratio increases, CD8 + (P 〈 0. 05 ) before and after the treatment group, the comparison, there was no significant difference ( P 〉 0.05 ). Conclusion :Jianpirougan can reduce the liver tissue inside liver fibrosis, and promote hyperplasia of liver cell regeneration function, imorove the immune function, achieve anti fibrosis.
出处
《中医学报》
CAS
2010年第6期1175-1177,共3页
Acta Chinese Medicine
关键词
慢性肝炎
肝纤维化
健脾柔肝汤
chronic hepatitis
hepatic fibrosis
jianpirougan decoction